Results 21 to 30 of about 47,738 (289)

Secondary and tertiary hyperparathyroidism in chronic kidney disease

Остеопороз и остеопатии, 2017
In the treatment of secondary hyperparathyroidism of end-stage chronic kidney disease, vitamin D receptor activation and allosteric modulators of the calcium-sensing receptor inhibit glandular hyperplasia, reduce parathyroid hormone levels, impact on ...
Lilit V. Egshatyan, Natalya G. Mokrisheva, Lyudmila Ya. Rozhinskaya   +2 more
doaj   +1 more source

Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report

Journal of Medical Case Reports, 2012
Introduction In the treatment of secondary hyperparathyroidism of chronic kidney disease, calcimimetics - allosteric modulators of the calcium-sensing receptor - inhibit glandular hyperplasia and significantly reduce circulating parathyroid hormone ...
Conzo Giovanni, Perna Alessandra F, Napolitano Salvatore, Mauriello Claudio, Gambardella Claudio, Satta Ersilia, Ciancia Giuseppe, Capasso Giovanbattista, Santini Luigi   +8 more
doaj   +1 more source

Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review

Frontiers in Endocrinology, 2023
Tenofovir disoproxil fumarate is the first-line antiviral therapy for chronic viral hepatitis B, but long-term use is associated with renal failure and hypophosphatemic osteomalacia.
Jing Zeng, Peng Ye, Dong Wei, Lan Li, Wanxia Ma   +4 more
doaj   +1 more source

Medical management and rehabilitation in a patient with avas-cular necrosis of the femoral head in the context of vitamin D deficiency and secondary hyperparathyroidism – case report [PDF]

Balneo and PRM Research Journal, 2023
Vitamin D is essential in determining bone and muscle health. Vitamin D deficiency (VDD) produces secondary hyperparathyroidism, loss of bone quality and mass, mineral-ization effects and fractures, myopathy, and falls.
Cosmina Diaconu, Remus Calin Cipăian, Mădălina Gabriela Iliescu, Viorela-Mihaela Ciortea, Laszlo Irsay, Rodica Ana Ungur, Cristinel Gabriel Diaconu   +6 more
doaj   +1 more source

Multiple brown tumors—Forgotten pathology in times of calcimimetics: A case report and literature review

SAGE Open Medical Case Reports, 2021
Multiple brown tumors represent a rare variant of osteitis fibrosa cystica. Brown tumors are associated with primary, secondary, or tertiary hyperparathyroidism. Brown tumors have been reported in patients with chronic kidney disease resulting in mineral
José Carlos De La Flor Merino, Pablo Justo, Juan J. Domínguez, Ana Gómez-Berrocal, Antonio E. Seva, Alexander Marschall, Miguel Rodeles   +6 more
doaj   +1 more source

Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy

Frontiers in Endocrinology, 2023
IntroductionFollowing total parathyroidectomy (PTx), transcervical thymectomy, and forearm autograft for secondary hyperparathyroidism (SHPT), recurrent SHPT can occur in the autografted forearm.
Takahisa Hiramitsu, Yuki Hasegawa, Kenta Futamura, Manabu Okada, Norihiko Goto, Shunji Narumi, Yoshihiko Watarai, Yoshihiro Tominaga, Toshihiro Ichimori   +8 more
doaj   +1 more source

The calcium-sensing receptor as a regulator of cellular fate in normal and pathological conditions [PDF]

, 2013
The calcium-sensing receptor (CaSR) belongs to the evolutionarily conserved family of plasma membrane G protein-coupled receptors (GPCRs). Early studies identified an essential role for the CaSR in systemic calcium homeostasis through its ability to ...
Benoit, Yves, D'Herde, Katharina, Diez Fraile, Araceli, Lammens, Tim   +3 more
core   +1 more source

Association between pruritus and serum concentrations of parathormone, calcium and phosphorus in hemodialysis patients. [PDF]

, 2013
Chronic renal disorders have a progressive course in most cases, and finally result in end-stage renal disease (ESRD). Hemodialysis (HD) is one of the mainstays in the treatment of these patients. Disturbance in calcium (Ca) and phosphorus (P) metabolism
Bayzayi, F., Haddad, M., Joshaghani, H.R., Qorbani, M., Tajbakhsh, R.   +4 more
core   +2 more sources

PARATHYROID CANCER OCCURRING IN RELAPSING SECONDARY HYPERPARATHYROIDISM

Alʹmanah Kliničeskoj Mediciny, 2016
We present a clinical case of parathyroid cancer in a patient with relapsing secondary hyperparathyroidism at 4 years after subtotal parathyroidectomy.
I. V. Kotova, I. A. Voronkova, I. A. Kazantseva   +2 more
doaj   +1 more source

Genetic background influences tumour development in heterozygous Men1 knockout mice [PDF]

, 2020
Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder caused by MEN1 germline mutations, is characterised by parathyroid, pancreatic and pituitary tumours. MEN1 mutations also cause familial isolated primary hyperparathyroidism (FIHP)
Christie, Paul T., Javid, Mahsa, Kooblall, Kreepa G., Lines, Kate E., Mallon, Ann-Marie, Newey, Paul J., Piret, Sian E., Reed, Anita Ac, Simon, Michelle, Stevenson, Mark, Thakker, Rajesh V., Walls, Gerard V.   +11 more
core   +2 more sources